ArticleJournal of the American Heart Association2015

Adequate Selection of a Therapeutic Site Enables Efficient Development of Collateral Vessels in Angiogenic Treatment With Bone Marrow Mononuclear Cells.

Masaru Nemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.